Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain

Gaceta Sanitaria

Volumn 27, Issue 4, 2013, Pages 338-343

  Folch, Cinta ^a,b,c   Casabona, Jordi ^a,b,c   Espelt, Albert ^b,c,d   Majó, Xavier ^e   Meroño, Mercè ^f   Gonzalez, Victoria ^a,b,g   Brugal, Maria Teresa ^b,d  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e Universitat Autònoma de Barcelona ^*  (Spain)

^f Àmbit Prevenció Foundation Ciutat Vella District   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Gender; Hepatitis C; HIV; Intravenous injection; Risk behaviours; Substance abuse

Indexed keywords

ABUSO DE SUSTANCIAS; ADULT; ARTICLE; COMPARATIVE STUDY; CONDUCTAS DE RIESGO; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GÉNERO; GENDER; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK BEHAVIOURS; SEX DIFFERENCE; SEXUAL BEHAVIOR; SPAIN; SUBSTANCE ABUSE; USUARIOS DE DROGAS POR VÍA PARENTERAL; VIH;

ABUSO DE SUSTANCIAS; CONDUCTAS DE RIESGO; GÉNERO; GENDER; HEPATITIS C; HIV; INTRAVENOUS INJECTION; RISK BEHAVIOURS; SUBSTANCE ABUSE; USUARIOS DE DROGAS POR VÍA PARENTERAL; VIH;

ADULT; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK-TAKING; SEX FACTORS; SEXUAL BEHAVIOR; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84880046512     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2013.02.006     Document Type: Article

References (39)

1. Silva V.N., d'Oliveira A.F., Mesquita F. Vulnerability to HIV among female injecting drug users. Rev Saude Publica 2007, 41(Suppl. 2):22-30.
2. Cleland C.M., Des Jarlais D.C., Perlis T.E., et al. HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health 2007, 7:271.
3. Booth R.E. Gender differences in high-risk sex behaviours among heterosexual drug injectors and crack smokers. Am J Drug Alcohol Abuse 1995, 21:419-432.
4. Dorman A., Keenan E., Schuttler C., et al. HIV risk behaviour in Irish intravenous drug users. Ir J Med Sci 1997, 166:235-238.
5. Magnus M., Kuo I., Phillips G., et al. Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health 2012, 90:157-166.
6. Absalon J., Fuller C.M., Ompad D.C., et al. Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. AIDS Behav 2006, 10:707-715.
7. Cintra A.M., Caiaffa W.T., Mingoti S.A., et al. Characteristics of male and female injecting drug users of the AjUDE-Brasil II Project. Cad Saude Publica 2006, 22:791-802.
8. Gollub E.L., Rey D., Obadia Y., et al. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis 1998, 25:483-488.
9. Riehman K.S., Kral A.H., Anderson R., et al. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health 2004, 81:249-259.
10. Barrio G., De la Fuente L., Toro C., et al. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors. Epidemiol Infect 2007, 135:592-603.
11. De Boni R., Pechansky R., Van Diernen L., et al. Diferenças entre fatores de risco para infecção pelo HIV em UDI do Rio de Janeiro e Porto Alegre. Rev Psiquiatr Clín 2005, 32:5-9.
12. Strathdee S.A., Galai N., Safaiean M., et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 2001, 161:1281-1288.
13. Pinkham S., Stoicescu C., Myers B. Developing effective health interventions for women who inject drugs: key areas and recommendations for program development and policy. Adv Preve Med 2012, 2012:269123. 10.1155/2012/269123.
14. Annual report 2006. Selected issue 2: a gender perspective on drug use and responding to drug problems 2006, European Monitoring Centre for Drugs and Drug Addiction, Publications Office of the European Union, Luxemburg.
15. Estébanez P.E., Russell N.K., Aguilar M.D., et al. Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 2000, 29:734-743.
16. De la Fuente L., Bravo M.J., Barrio G., et al. Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. Clin Infect Dis 2003, 37(Suppl. 5):S410-S415.
17. Hurtado Navarro I., Alastrue I., Del Amo J., et al. Differences between women and men in serial HIV prevalence and incidence trends. Eur J Epidemiol 2008, 23:435-440.
18. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). SIVES 2010: Sistema Integrado de Vigilancia Epidemiológica del SIDA/VIH/ITS en Catalunya (SIVES): informe bianual. Barcelona: Generalitat de Catalunya, Departament de Salut; 2011. Documento técnico CEEISCAT, 2010.
19. Multy-city study on drug injecting and risk of HIV infection. Programme on substance abuse - final report 1994, World Health Organization, WHO, Geneva.
20. Chohan B.H., Lavreys L., Mandaliya K.N., et al. Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clin Diagn Lab Immunol 2001, 8:346-348.
21. Judd A., Parry J., Hickman M., et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003, 71:49-55.
22. Folch C., Casabona J., Brugal M.T., et al. Sexually transmitted infections and sexual practices among injecting drug users in harm reduction centers in Catalonia. Eur Addict Res 2011, 17:271-278.
23. Brooks A., Meade C.S., Potter J.S., et al. Gender differences in the rates and correlates of HIV risk behaviors among drug abusers. Subst Use Misuse 2010, 45:2444-2469.
24. Bogart L.M., Kral A.H., Scott A., et al. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sex Transm Dis 2005, 32:27-34.
25. Uuskula A., Abel-Ollo K., Markina A., et al. Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia. Sex Transm Infect 2012, 88:58-62.
26. Benotsch E.G., Somlai A.M., Pinkerton S.D., et al. Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs. Int J STD AIDS 2004, 15:343-347.
27. Platt L., Rhodes T., Judd A., et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. Am J Public Health 2007, 97:478-485.
28. Azim T., Chowdhury E.I., Reza M., et al. Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a cohort study. Harm Reduct J 2006, 3:33.
29. Blankenship K.M., Koester S. Criminal law, policing policy, and HIV risk in female street sex workers and injection drug users. J Law Med Ethics 2002, 30:548-559.
30. Frajzyngier V., Neaigus A., Gyarmathy V.A., et al. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 2007, 89:145-152.
31. Bennett G.A., Velleman R.D., Barter G., et al. Gender differences in sharing injecting equipment by drug users in England. AIDS Care 2000, 12:77-87.
32. Sherman S.G., Latkin C.A., Gielen A.C. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse 2001, 36:2113-2136.
33. Barnard M.A. Needle sharing in context: patterns of sharing among men and women injectors and HIV risks. Addiction 1993, 88:805-812.
34. Freeman R.C., Rodríguez G.M., French J.F. A comparison of male and female intravenous drug users' risk behaviors for HIV infection. Am J Drug Alcohol Abuse 1994, 20:129-157.
35. Steen R., Wi T.E., Kamali A., et al. Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm. Bull World Health Organ 2009, 87:858-865.
36. Quinn T.C., Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005, 308:1582-1583.
37. Des Jarlais D.C., Feelemyer J.P., Modi S.N., et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs? An international systematic review of high seroprevalence areas. Drug Alcohol Depend 2012, 124:95-107.
38. Goldstein M.F., Friedman S.R., Neaigus A., et al. Self-reports of HIV risk behavior by injecting drug users: are they reliable?. Addiction 1995, 90:1097-1104.
39. Ashley O.S., Marsden M.E., Brady T.M. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 2003, 29:19-53.